We found no significant difference in the cumulative risk of death from BC between cases with CN ≥4 of PAK1 alone, CN ≥4 CCND1 alone, and cases with CN ≥4 for both PAK1 and CCND1 combined (Fig 4). This evidence concerns the gene CCND1 and breast cancer.